HCWB
Income statement / Annual
Last year (2023), HCW Biologics Inc.'s total revenue was $2.84 M,
a decrease of 57.72% from the previous year.
In 2023, HCW Biologics Inc.'s net income was -$24.99 M.
See HCW Biologics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.84 M |
$6.72 M |
$0.00 |
$4.10 M |
$0.00 |
| Cost of Revenue |
$2.28 M
|
$4.14 M
|
$543,598.00
|
$0.00
|
$421,817.00
|
| Gross Profit |
$560,360.00
|
$2.59 M
|
-$543,598.00
|
$4.10 M
|
-$421,817.00
|
| Gross Profit Ratio |
0.2
|
0.38
|
0
|
1
|
0
|
| Research and Development Expenses |
$7.68 M
|
$9.34 M
|
$8.17 M
|
$7.26 M
|
$5.39 M
|
| General & Administrative Expenses |
$13.08 M
|
$8.33 M
|
$4.98 M
|
$2.44 M
|
$1.80 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.08 M
|
$8.33 M
|
$4.98 M
|
$2.44 M
|
$1.80 M
|
| Other Expenses |
$5.52 M
|
$304,735.00
|
$218,466.00
|
$233,039.00
|
$171,418.00
|
| Operating Expenses |
$26.28 M
|
$17.67 M
|
$13.37 M
|
$9.92 M
|
$7.37 M
|
| Cost And Expenses |
$28.56 M
|
$21.80 M
|
$13.37 M
|
$9.92 M
|
$7.37 M
|
| Interest Income |
$0.00
|
$126,660.00
|
$505,366.00
|
$22,324.00
|
$72,353.00
|
| Interest Expense |
$283,042.00
|
$126,660.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.14 M
|
$589,608.00
|
$543,598.00
|
$572,867.00
|
$421,817.00
|
| EBITDA |
-$23.58 M |
-$14.18 M |
-$12.82 M |
-$5.25 M |
-$6.94 M |
| EBITDA Ratio |
-8.3
|
-2.2
|
0
|
-1.28
|
0
|
| Operating Income Ratio |
-9.05
|
-2.24
|
0
|
-1.42
|
0
|
| Total Other Income/Expenses Net |
$722,883.00
|
$178,075.00
|
$505,366.00
|
$22,324.00
|
$72,353.00
|
| Income Before Tax |
-$24.99 M
|
-$14.90 M
|
-$12.86 M
|
-$5.80 M
|
-$7.29 M
|
| Income Before Tax Ratio |
-8.8
|
-2.22
|
0
|
-1.42
|
0
|
| Income Tax Expense |
$0.00
|
-$178,075.00
|
-$505,366.00
|
-$22,324.00
|
-$72,353.00
|
| Net Income |
-$24.99 M
|
-$14.72 M
|
-$12.36 M
|
-$5.78 M
|
-$7.22 M
|
| Net Income Ratio |
-8.8
|
-2.19
|
0
|
-1.41
|
0
|
| EPS |
-0.7 |
-0.41 |
-0.35 |
-0.16 |
-0.2 |
| EPS Diluted |
-0.7 |
-0.41 |
-0.35 |
-0.16 |
-0.2 |
| Weighted Average Shares Out |
$35.93 M
|
$35.82 M
|
$35.77 M
|
$36.70 M
|
$36.70 M
|
| Weighted Average Shares Out Diluted |
$35.93 M
|
$35.82 M
|
$35.77 M
|
$36.70 M
|
$36.70 M
|
| Link |
|
|
|
|
|
